- Home
- ABBV vs APH Comparison
ABBV vs APH Comparison
Compare ABBV & APH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABBV | APH |
|---|---|---|
| Founded | 2012 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 194.1B |
| IPO Year | 2012 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ABBV | APH |
|---|---|---|
| Price | $262.82 | $161.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 12 |
| Target Price | ★ $253.71 | $154.00 |
| AVG Volume (30 Days) | 3.7M | ★ 6.5M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.39% | 0.67% |
| EPS Growth | N/A | ★ 73.96 |
| EPS | ★ 2.42 | 2.10 |
| Revenue | ★ $61,160,000,000.00 | N/A |
| Revenue This Year | $11.87 | $37.60 |
| Revenue Next Year | $8.12 | $12.19 |
| P/E Ratio | $109.82 | ★ $75.60 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $190.75 | $105.45 |
| 52 Week High | $267.47 | $178.52 |
Technical Indicators
Market Signals| Indicator | ABBV | APH |
|---|---|---|
| Relative Strength Index (RSI) | 59.39 | 49.57 |
| Support Level | $242.14 | $154.68 |
| Resistance Level | $267.22 | $167.94 |
| Average True Range (ATR) | 4.70 | 4.70 |
| MACD | 1.08 | -1.14 |
| Stochastic Oscillator | 81.59 | 40.85 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About APH Amphenol Corporation
Amphenol is a global supplier of connectors, sensors, and interconnect systems. It holds the second-largest connector market share globally and sells into the automotive, broadband, commercial air, industrial, IT and data communications, military, mobile devices, and mobile networks end markets. Amphenol is diversified geographically, with operations in 40 countries.